These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 1271242)

  • 21. Inconsistencies in rationale underlying official USP dissolution rate specifications for nitrofurantoin.
    Bates TR; Rosenberg HA; Tembo AV
    J Pharm Sci; 1973 Dec; 62(12):2057-8. PubMed ID: 4762187
    [No Abstract]   [Full Text] [Related]  

  • 22. [Study of the statistical characteristics of the USP XXI content uniformity sampling plan for tablets].
    Tao QF; Zhong DF; Luo X; Wang X
    Yao Xue Xue Bao; 1987 Mar; 22(3):212-6. PubMed ID: 3661209
    [No Abstract]   [Full Text] [Related]  

  • 23. Development and validation of dissolution tests for fexofenadine hydrochloride capsules and coated tablets.
    Breier AR; Paim CS; Steppe M; Schapoval EE
    J Pharm Pharm Sci; 2005 Aug; 8(2):289-98. PubMed ID: 16124939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physicochemical quality profiles of commercial oral tablets and capsules containing lutein - impact of insufficient specific sanitary regulations.
    Anselmo CS; Mendes TC; Cabral LM; Sousa VP
    An Acad Bras Cienc; 2018; 90(3):3063-3073. PubMed ID: 30043910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The USP content uniformity test. Analysis and proposals.
    Setnikar I
    Pharm Acta Helv; 1974; 49(9-10):302-8. PubMed ID: 4462139
    [No Abstract]   [Full Text] [Related]  

  • 26. Gelatin capsules in the pharmacopoeiae.
    Jones BE; Törnblom JF
    Pharm Acta Helv; 1975; 50(3):33-45. PubMed ID: 1121513
    [No Abstract]   [Full Text] [Related]  

  • 27. Objective visual evaluation of the relative content of major and minor defects in tablets and capsules.
    Stone JC
    J Pharm Sci; 1970 Sep; 59(9):1364. PubMed ID: 5469814
    [No Abstract]   [Full Text] [Related]  

  • 28. [The dissolution rate of certain administration forms of packaged drugs].
    Pharm Weekbl; 1973 Jan; 108(3):54-6. PubMed ID: 4699089
    [No Abstract]   [Full Text] [Related]  

  • 29. Multiple level C in vitro/in vivo correlation of dissolution profiles of two L-thyroxine tablets with pharmacokinetics data obtained from patients treated for hypothyroidism.
    Volpato NM; Silva RL; Brito AP; Gonçalves JC; Vaisman M; Noël F
    Eur J Pharm Sci; 2004 Apr; 21(5):655-60. PubMed ID: 15066666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Content uniformity more important than dissolution in hand-filled capsules.
    Eisen H
    Am J Hosp Pharm; 1987 Aug; 44(8):1775-6. PubMed ID: 3631100
    [No Abstract]   [Full Text] [Related]  

  • 31. Shear distribution and variability in the USP Apparatus 2 under turbulent conditions.
    Kukura J; Baxter JL; Muzzio FJ
    Int J Pharm; 2004 Jul; 279(1-2):9-17. PubMed ID: 15234789
    [TBL] [Abstract][Full Text] [Related]  

  • 32. USP standards for dissolution and bioavailability.
    Grady LT
    Am J Hosp Pharm; 1982 Sep; 39(9):1546-8. PubMed ID: 7137198
    [No Abstract]   [Full Text] [Related]  

  • 33. A comparative study of BP and USP rotating basket dissolution apparatus.
    Smith WJ; Heaume PE; Hailey DM; Lea AR
    J Pharm Pharmacol; 1985 Feb; 37(2):124-5. PubMed ID: 2858545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lot-to-lot variation in dissolution of tolbutamide tablets.
    Ayres JW
    Am J Hosp Pharm; 1980 Oct; 37(10):1329-32. PubMed ID: 7424928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Product dissolution methods: response.
    Tingstad JE
    J Pharm Sci; 1973 Jul; 62(7):VI. PubMed ID: 4714144
    [No Abstract]   [Full Text] [Related]  

  • 36. Differences between USP and BP dissolution results for oxytetracycline capsules after accelerated stability testing.
    Swanepoel E; Liebenberg W; de Villiers MM
    Pharmazie; 2003 Aug; 58(8):601-2. PubMed ID: 12967045
    [No Abstract]   [Full Text] [Related]  

  • 37. Hydrodynamics-induced variability in the USP apparatus II dissolution test.
    Baxter JL; Kukura J; Muzzio FJ
    Int J Pharm; 2005 Mar; 292(1-2):17-28. PubMed ID: 15725550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unexpected variable in the USP-NF rotating dissolution test.
    Beyer WF; Smith DL
    J Pharm Sci; 1971 Mar; 60(3):496-7. PubMed ID: 5572144
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of relative humidity on drug release from phenytoin sodium tablets and capsules. Part 1: Commercial preparations.
    Akbuğa J; Ari-Ulubelen A; Bayraktar-Alpmen G
    Pharmazie; 1984 Aug; 39(8):560-1. PubMed ID: 6504981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Studies on dissolution rate in vitro of silymarin dropping pill].
    Sun X; Qiu MF; Li SS; Wang JX; Shen Q; Jia W
    Zhongguo Zhong Yao Za Zhi; 2005 Feb; 30(4):263-5. PubMed ID: 15724400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.